Phillip Minnick, Ph.D.

Knobbe Martens

Contact
View Bio
RSS

Latest Posts › Food and Drug Administration (FDA)

Share:

Rare Disease Therapies Gain Momentum With Regulatory Support and Continued Market Growth

The landscape for rare disease treatments appears to be evolving rapidly, thanks to a confluence of regulatory momentum and a booming market forecast. Statements from key federal figures in recent months combined with market...more

6/20/2025  /  Food and Drug Administration (FDA) , Government Agencies , Healthcare , Life Sciences , Orphan Drugs , Pharmaceutical Industry , Prescription Drugs , Regulatory Reform , Regulatory Requirements
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide